| 1 |
27923166 | A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome. | 2017 Mar |
2 |
| 2 |
19931080 | Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome. | 2010 Oct |
3 |
| 3 |
16199428 | Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance. | 2006 Jan |
1 |
| 4 |
16595221 | Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. | 2006 Feb |
1 |
| 5 |
16116971 | Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome. | 2005 |
2 |
| 6 |
15697105 | Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes. | 2004 Sep |
1 |
| 7 |
12915645 | Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. | 2003 Aug |
1 |
| 8 |
14682006 | [Cyproterone acetate improves beta-cell function in postmenopausal women with diabetes mellitus type 2]. | 2003 |
2 |